Pharm.D.
496.
Topics in Pharmacy.
(1 to a maximum of 3 ∆)
Restriction: permission of instructor.
497.
Problems in Pharmacy.
(1-5, no limit ∆)
Research and library problems in some phase of pharmacy. Not for professional students in the College of Pharmacy curriculum.
Restriction: permission of instructor.
498.
Problems in Pharmacy.
(1-5, no limit ∆)
Research and library problems in some phase of pharmacy. Not for professional students in the College of Pharmacy curriculum.
Restriction: permission of instructor.
511 / 773.
Nuclear Pharmacy Instrumentation.
(3)
Structure and properties of atoms, radiation and radioactive decay, production of radionuclides, interactions of radiation with matter, with emphasis on instrumentation for radiation detection and measurement in a nuclear pharmacy or nuclear medicine environment.
Restriction: permission of instructor.
512 / 774.
Radiopharmaceutical Chemistry.
(1)
Introduces undergraduate students to inorganic chemistry as applicable to radiopharmaceuticals.
Prerequisite: CHEM 302 or equivalent.
Restriction: permission of instructor.
514.
Basics of Nuclear Pharmacy Practice.
(2)
Restriction: permission of instructor.
516 / 776.
Radiopharmacology.
(3)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
518.
In-Vitro Radiotracer Procedures.
(2)
This course will provide the principles of in-vitro methods such as radioimmunoassay, autoradiography, ferrokinetics, radiometic assay, x-ray fluorescence and neutron activation analysis.
Restriction: permission of instructor.
519L.
Instrumentation and In Vitro Lab.
(2)
Practical experience in in-vitro radiotracer techniques and instrumentation in nuclear pharmacy.
Restriction: permission of instructor.
521.
Radiopharmaceutics.
(2)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
523.
Clinical Nuclear Medicine.
(1)
The utility of nuclear medicine procedures in the diagnostic work-up of patients with various diseases is presented using case studies illustrated by data obtained from multiple imaging modalities.
Prerequisite: (511 or 773) and BIOL 238.
535.
Administrative Clerkship.
(3-5, no limit ∆)
Student placement in local/state health agencies, planning boards and legislative staff for health policy development. Field coordinators would identify projects in concert with faculty.
545-546.
Pharmacy and Its Environment.
(3, 3)
Exploration of the cultural foundations of pharmacy. Development of the present state of practice. Social and psychological factors in drug use. Role of the pharmacist as a health practitioner.
547.
Pharmacy Practice Research.
(3)
An introduction for graduate students in pharmacy administration to issues in pharmacy practice research. Research process, methods, measurement, tools, designs and ethics.
548.
Ethics Clinical Trials/Informed Consent.
(2)
The study of the history, ethical versus scientific methodological conflicts, and other issues that are generated by the conduct of randomized controlled clinical trials using human beings.
549.
Regulatory Issues in Clinical Trials.
(2)
The study of federal regulations and guidelines that govern the planning and conduct of randomized controlled clinical trials in humans with drugs and devices.
550.
Pharmacoeconomics and Patient Outcomes Research in Medicine.
(3)
The study of the economic results associated with pharmaceutical treatment or care and consequences of health care, including clinical (healing, disease/symptom remission), humanistic (satisfaction, health-related quality of life, societal utility), and economic (costs/savings).
576.
Molecular and Cellular Pharmacology.
(3)
Basic principles and recent advances underpinning modern molecular and cellular pharmacology. Topics include receptor theory, drug metabolism and biotransformation, pharmacogenomics, receptors and signal transduction, rationale drug design and selected topics in organ-system based pharmacology.
Prerequisite: BIOM 509 or BIOM 510.
{Fall}
580.
General Toxicology.
(3)
An in-depth introduction to the basic principles and concepts of toxicology. Categories of chemicals causing toxic effects, the manner of exposure to toxic substances, the environmental and biological effects, and the laws and regulations will be considered.
Restriction: admitted to Pharmacy M.S. or Ph.D. degree program.
591.
Seminar in Administrative Pharmacy.
(1, no limit ∆)
This course will give the students experience in organizing and presenting their thoughts and interpretations on a selected subject. The seminar will provide the student with an opportunity to develop writing and formal oral presentation skills.
Restriction: permission of instructor.
592.
Seminar in Radiopharmacy.
(1, no limit ∆)
Each masters candidate will be required to present a seminar on a topic of choice approved by his/her supervisor or selected by the supervisor.
Restriction: permission of instructor.
593.
Seminars in Toxicology.
(1, no limit ∆)
Research seminars on current topics in Toxicology will be presented by students and faculty from within UNM and from invited speakers outside of UNM.
Restriction: permission of instructor.
594.
Topics in Environmental Disease.
(1-3 to a maximum of 4 ∆)
Advanced readings in topics relating to toxicology and environmental disease, including areas such as chemical teratogenesis, reactive oxygen species, respiratory toxicology, receptor-medicated toxicology and environmentally induced cancer.
Prerequisite: 580.
Restriction: permission of instructor.
{Fall, Spring}
597.
Research Problems in Pharmaceutical Sciences.
(1-5 to a maximum of 12 ∆)
Research in pharmaceutical sciences.
Restriction: permission of instructor.
598.
Topics in Pharmaceutical Sciences.
(1-3 to a maximum of 4 ∆)
Advanced readings in topics relating to the pharmaceutical sciences in the areas of hospital pharmacy, pharmacy administration, radiopharmacy or toxicology.
Restriction: permission of instructor.
599.
Master’s Thesis.
(1-6, no limit ∆)
Offered on a CR/NC basis only.
699.
Dissertation.
(1-9, no limit ∆)
Offered on a CR/NC basis only.
701.
Pharmaceutics I. (Pharmaceutical Dosage Forms I) .
(3)
Study of pharmaceutical dosage forms and relevant physico-chemical and biopharmaceutical principles. Introduction to the metrology and calculations involved in the compounding and dispensing of pharmaceutical preparations.
702.
Pharmaceutics II.
(3)
Continuation of 701.
703L.
Pharmaceutical Care Lab I.
(3)
Introduction to the “languages and tools” used in contemporary pharmacy practice. Emphasis on calculations, communication, drug information, product formulation, and problem-solving.
704L.
Pharmaceutical Care Lab II.
(3)
Continuation of 703L with additional emphasis on patient information, assessment and monitoring; prescription processing; patient counseling; drug administration techniques; laboratory and home diagnostics tests; consult notes; and professional presentations.
705.
Pathophysiology.
(4)
Pathological consequences of disease states, including clinical presentation and histological findings presented by organ systems. Includes an introduction to medical terminology.
706.
Foundations of Drug Action.
(4)
An introduction to the molecular and chemical mechanisms of therapeutic agents. Topics include biochemical processes and drug targets, gene regulation and expression, cell signaling, and drug absorption, distribution, metabolism, and excretion processes.
707.
Pharmacy and Health Care Delivery.
(2)
Marketing and economic concepts of pharmacy practice, with a focus towards marketing of pharmaceutical services and products, pharmacy finance and economics in operations, pharmacoeconomics and decision-making.
709.
Introduction to Pharmacy Practice.
(1)
An introduction to the profession of pharmacy including career options, ethical principles, the responsibilities of being a health professional, the professional literature, and personal portfolio development.
710.
Mechanisms of Drug Action I.
(5)
First in a series of courses addressing principles of pharmacology, medicinal chemistry and biochemical mechanisms of drug action and toxicity. This section will specifically cover basics of drug metabolism and the pharmacology, structure-activity relationships (SAR), toxicology and elimination of drugs that act upon the autonomic nervous system.
713.
Pharmaceutical Calculations.
(1)
This course will introduce students to the knowledge and skills of fundamental mathematical calculations utilized in pharmacy practice.
715.
Pathophysiology II.
(4)
A continuation of Pharmacy 705.
717.
Introductory Pharmacy Law.
(1)
An introduction to the Federal and New Mexico laws that relate to the practice of pharmacy.
718L.
Pharmaceutical Care Lab III.
(2)
Continuation of 704L. Activities parallel topics in concurrent self-care therapeutics and literature evaluation courses. Emphasis on patient assessment, care planning, and monitoring; critical literature appraisal; and written communication skills.
719.
Self-Care Therapeutics.
(3)
A pharmacotherapeutics course studying the use of non-prescription drugs, supplies, and herbal medicinals with emphasis on the pharmacist’s role as advisor, communicator, and educator to patients.
720.
Introduction to Nuclear Pharmacy.
(2)
This course provides an overview of nuclear pharmacy as a practice specialty: contributions of the nuclear pharmacist and application of radioactive tracer techniques in the diagnosis and treatment of disease will be reviewed.
726.
Pharmacokinetics and Biopharmaceutics.
(3)
An introduction to the influence of absorption, distribution, metabolism, and excretion on the time course of drug levels in body and in understanding how changes in these processes affect the outcomes of drug therapies.
728.
Pharmacy Informatics and Research.
(3)
An examination of the structure of the biomedical literature and research with emphasis on the recognition, evaluation and application of different study types and the data they produce.
729.
Sterile Products.
(2)
The administrative (i.e., procedural) and pharmaceutical (i.e., preparation and dispensing) aspects of pharmacy-initiated (i.e., commercially-available and extemporaneously-prepared) sterile products.
731.
Mechanisms of Drug Action II.
(5)
Continuation of 710 addressing pharmacology, toxicology, SAR and elimination of prototypes in specific drug classes.
732.
Mechanisms of Drug Action III.
(5)
Continuation of 710 and 731 addressing pharmacology, toxicology, SAR and elimination of prototypes in specific drug classes.
733L.
Pharmaceutical Care Lab IV.
(2)
Continuation of 718L. Activites parallel topics in concurrent pharmacotherapy drug course, with emphasis on patient assessment, care planning, and monitoring; self-care practices and verbal communication skills.
739.
Pharmacotherapy I.
(6)
Introduces students to a systematic approach to patient-centered pharmaceutical care, emphasizing patient assessment, problem-solving, communication, and counseling skills. Begins pharmacotherapy sequence.
740.
Self-Selected Supplementary Pharmacy Education.
(1-2 to a maximum of 2 ∆)
This course is designed to allow students to self-identify areas for supplemental pharmacy education. Student will select and complete ACPE-approved continuing education programs.
748.
Research Project (Initial).
(1)
Student formulates hypothesis for research project and establishes methodologies for completion under guidance of faculty. Research project approved by committee. Offered on a CR/NC basis only
.
751.
Pharmacotherapy II.
(6)
Study of the therapy of common disease states by organ systems integrating the concepts from pathophysiology, pharmacology, biopharmaceutics, pharmacokinetics and pharmacoeconomics in the treatment of patients. Fully develops the concept of pharmaceutical care or how to provide the most cost-effective care of a patient including over-the-counter and natural remedies.
752.
Pharmacotherapy III.
(6)
Continuation of 751.
755.
Seminar in Pharmacy.
(1 to a maximum of 2 ∆)
Offered on a CR/NC basis only.
756.
Safe Medication Practices.
(2)
A study of the existence of medication errors, reasons for these errors and suggested methods to prevent them from occurring.
757.
Professional Presentation Skills.
(2)
Pharmacy seminar involves learning literature evaluation and presentation skills, and subsequently working independently to deliver one or more presentations on cutting edge topics in pharmacotherapy. This course includes time for both group discussion/literature evaluations and individual presentations.
758.
Research Project.
(1)
Student completes research project in final year. Up to four students may work collaboratively on one project.
Offered on a CR/NC basis only.
759.
Advanced Law and Ethics.
(2)
Emphasis given to statues and regulations regulating the practice of pharmacy and distribution of drugs including the New Mexico Pharmacy Practice Act. Class discussion will include the application of ethics to situations in health care.
760.
Pharmacy Healthcare Management and Economics.
(3)
Provides students with an overview of the principles of marketing of pharmaceutical services, managed care pharmacy, pharmacoeconomics and outcomes research, and personnel management.
761.
Introduction to Managed Care Pharmacy Practice.
(2)
Issues critical to managed care pharmacy practice will be introduced such as: disease management, formulary management, drug utilization review, benefit design and contracting, Medicare and Medicaid, distribution systems and network management, quality improvement, health informatics.
762L.
Pharmaceutical Care Lab V.
(2)
Continuation of 733L, activities parallel concurrent pharmacotherapy courses. Emphasis on patient assessment, care planning, and monitoring.
764.
Emerging Technologies in Pharmaceutical Care.
(1)
Provides students with an understanding of the principles of biotechnology, pharmacogenomic, and other state of the art therapies in pharmacy.
765L.
Pharmaceutical Care Lab VI.
(2)
Continuation of 762L, activities parallel concurrent pharmacotherapy courses. Emphasis on patient assessment, care planning, and monitoring.
766.
Public Health in Pharmacy.
(2)
This course provides students with an introduction to public health from a pharmacy perspective.
Restriction: admitted as PharmD student.
770.
Advanced Pharmacy Practice Experience.
(2-4 to a maximum of 36 ∆)
Consist of four-week clinical experiences (40 hours/week) where students provide direct pharmaceutical care to patients.
771.
Introductory Community Pharmacy Practice Experience.
(2 to a maximum of 4 ∆)
A four-week (40 hours/week) directed dispensing pharmacy experience. Students will be exposed to ambulatory patient care in a community pharmacy setting.
772.
Introductory Institutional Pharmacy Practice Experience.
(2 to a maximum of 4 ∆)
A four-week (40 hours/week) directed dispensing pharmacy experience. Students will be exposed to in-patient care in an institutional pharmacy setting.
773 / 511.
Nuclear Pharmacy Instrumentation.
(3)
Structure and properties of atoms, radiation and radioactive decay, production of radionuclides, interactions of radiation with matter, with emphasis on instrumentation for radiation detection and measurement in a nuclear pharmacy or nuclear medicine environment.
Restriction: permission of instructor.
774 / 512.
Radiopharmaceutical Chemistry.
(1)
Introduces undergraduate students to inorganic chemistry as applicable to radiopharmaceuticals.
Prerequisite: CHEM 302.
Restriction: permission of instructor.
775.
Radiopharmacy Health and Radiation Biology.
(3)
Fundamentals of the biological effects of ionizing radiation on living systems, especially man; basic biological mechanisms which bring about somatic and genetic effects. Concepts of radiation protection, radiation dosimetry, radiation monitoring and x-ray health physics.
Restriction: permission of instructor.
776 / 516.
Radiopharmacology.
(3)
Study of the physicochemical characteristics of radiopharmaceuticals; kinetics of radiopharmaceuticals; structure-distribution relationships of radiopharmaceuticals; considerations in the design of new radiopharmaceuticals.
Restriction: permission of instructor.
782.
Clinical Toxicology.
(2)
Study of the acute toxicity in humans of common drugs, chemicals and household products; physical and laboratory assessment of common poisonings; development of clinical management plans and role of pharmacists in prevention of poisonings. P3 standing in College of Pharmacy.
783.
Clinical Pharmacy Assessment.
(1)
A self-paced study of laboratory tests used in clinical pharmacy practice.
798.
Problems in Pharmacy.
(1-5 to a maximum of 10 ∆)
Research and library problems in some phases of pharmacy.
Restriction: permission of instructor.
799.
Nontraditional Pharm.
(2 to a maximum of 12 ∆)
A course for pharmacists with a B.S. degree to receive credit for correspondence and other didactic training toward the Pharm.D. degree. Course must be taken continuously during the didactic training.
Offered on a CR/NC basis only.
NOTE: PHRM 720, 729, 748, 755, 757, 758, 761, 782, 783 and 798 can be used to satisfy the pharmacy professional elective requirements.
